国家气象局 (NWS) 天气预报办公室 (WFO) 全年无休,24 小时不间断地为亚利桑那州居民提供天气、水文和气候预报和警告。全国共有 122 个 WFO,其中 3 个位于亚利桑那州。训练有素的预报员向公众、媒体、应急管理和执法官员、航空和航海界、农业利益相关方、企业等发布天气事件的警告和预报,包括强雷暴、龙卷风、飓风、冬季风暴、洪水和热浪。信息通过多种方式传播,包括无线应急警报、社交媒体、weather.gov 和 NOAA 气象广播全灾种。每个 WFO 都有一名预警协调气象学家,他们积极开展外联和教育计划,加强与应急管理、政府、媒体和学术界的当地合作伙伴的工作关系。在发生重大紧急情况(例如野火、洪水、化学品泄漏和重大恢复工作)时,预报员可通过远程和现场方式提供基于影响的决策支持服务 (IDSS)。为了收集用于预报和其他目的的数据,NWS WFO 工作人员会监控、维护和使用自动地面观测站和多普勒气象雷达。除了 WFO 之外,NWS 还在美国各地运营专门的国家预报中心和地区总部,共有 168 个运营单位。NWS 超过 85% 的员工都在现场工作。如需了解亚利桑那州的当前天气情况,请访问 www.weather.gov,然后在国家地图上单击相关县或地区。
by:/s/s/anjana samant anjana samant(d.d.c.栏号4267019)副法律顾问詹姆斯·格雷森(James Grayson)*首席副检察长史蒂芬·佩德(Steven Perfrement 270-4332新墨西哥州达娜·内塞尔总检察长,密歇根州,作者: / s / s / s / s / jason evans jason jason jason evans*助理司法部长约瑟夫·波顿(Joseph Potchen) 48933(517)335-7632 evansj@michigan.gov律师密歇根州人民
这篇论文是由Scholarworks的Walden论文和博士研究收集到您的免费和公开访问。它已被授权的学者管理员所接受的沃尔登论文和博士研究。有关更多信息,请联系Scholarworks@waldenu.edu。
* ...........................................................................................51 *ANTIMALARIALS* .................................................................................................................... 52 *ANTIMYASTHENIC/CHOLINERGIC AGENTS* .............................................................................52 *ANTIMYCOBACTERIAL AGENTS* ...............................................................................................53 *ANTINEOPLASTICS AND ADJUNCTIVE THERAPIES* ..................................................................53 *ANTIPARKINSON AND RELATED THERAPY AGENTS* ................................................................ 56 *ANTIPSYCHOTICS/ANTIMANIC AGENTS* ........................................................................................................................................................................................................................... ..................................................................................................................... 64 *CALCIUM CHANNEL BLOCKERS* ............................................................................................... 65 *CARDIOTONICS* ...................................................................................................................... 65 *CARDIOVASCULAR AGENTS - MISC.在 .................................................................................................................. 67 *CORTICOSTEROIDS* ................................................................................................................ 75 *COUGH/COLD/ALLERGY* ......................................................................................................... 77 *DERMATOLOGICALS* ............................................................................................................................................................................................................................................................................................................................................................. ........................................................................................................................... 120 *ENDOCRINE AND METABOLIC AGENTS - MISC.* ......................................................................121 *ESTROGENS* .......................................................................................................................... 123 *FLUOROQUINOLONES* ........................................................................................................... 124 *GASTROINTESTINAL AGENTS - MISC.* ................................................................................... 124 *GENITOURINARY AGENTS - MISCELLANEOUS* ....................................................................... 127 *GOUT AGENTS* .......................................................................................................................128 *HEMATOLOGICAL AGENTS - MISC.* ........................................................................................ 129 *HEMATOPOIETIC AGENTS* ..................................................................................................... 131 *HEMOSTATICS* ...................................................................................................................... 134
随着年龄衰老的迅速增加,与年龄相关的神经退行性疾病的流行率(如阿尔茨海默氏病(AD))显着上升,2023年全球超过5500万人影响了超过5500万人,该项目表明,到2030年,该数字将超过7800万(更好,2023年)。尽管大量研究集中在老年人中理解和治疗AD上,但越来越强调早期干预以防止其发作(Crous-Bou等,2017; Dohm-Hansen等,2024)。在这方面,中年已获得了作为AD开发和预防的关键时期的认可(Ritchie等,2017)。例如,包括糖尿病,肥胖和高血压在内的中年血管危险因素增加了晚期发展AD的风险(Livingston等,2020)。本研究主题包括八项人类和啮齿动物研究,包括三篇评论论文,探索降低与年龄相关的认知下降风险和与年龄相关的记忆力下降的机制,中年人的记忆下降,患有正常认知的老年人,患有轻度认知障碍的老年人(MCI)以及患有AD的人。
COPY of the foregoing electronically delivered this ______ day of February, 2025, to: Barbara D. Richardson, Director Tom Zuppan, Hearing Officer Alena Caravetta, Regulatory Legal Affairs Officer Arizona Department of Insurance and Financial Institutions 100 North 15th Avenue, Suite 261 Phoenix, Arizona 85007 AMI Risk Consultants, Inc. gailf@amirisk.com arvin.delrosario@amirisk.com佛罗里达州NAIC#60275 LESLIE SOLER LESLIE.SOLER.SOLER.SOLER.SOLER@ASSURANT@ASSURANT.COM美国健康和生活Ins。Co. NAIC#60518 GREGG LEHMAN GREGG.H.LEHMAN@OMF.com Linda Frazier linda.j.frazier@omf.com faye johnson johnsonf@omf.com Co. NAIC#60739 Robert Zahirniak Robert.zahirniak@americannational.com nate ackerknecht nathan.ackerknecht@americannational.comCo. NAIC#60518 GREGG LEHMAN GREGG.H.LEHMAN@OMF.com Linda Frazier linda.j.frazier@omf.com faye johnson johnsonf@omf.comCo. NAIC#60739 Robert Zahirniak Robert.zahirniak@americannational.com nate ackerknecht nathan.ackerknecht@americannational.comCo. NAIC#60739 Robert Zahirniak Robert.zahirniak@americannational.com nate ackerknecht nathan.ackerknecht@americannational.com